Novel treatments in pipeline for diabetic eye disease

Article
Conference|AAO

Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.


Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

Recent Videos
Marion Munk, MD, PhD, presenting slides
Marion Munk, MD, PhD, presenting slides
Related Content
Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results

Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results

Sydney M Crago
November 21st 2024
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
December 1st 2020
Podcast
AlloVir, Inc. enters definitive merger agreement to combine with Kalaris Therapeutics

AlloVir, Inc. enters definitive merger agreement to combine with Kalaris Therapeutics

Sydney M Crago
November 18th 2024
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
November 5th 2020
Podcast
The deep dish on all things ophthalmology at AAO 2024

The deep dish on all things ophthalmology at AAO 2024

Hattie Hayes;Sydney M Crago
November 16th 2024
Article
Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomes

Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomes

Sean D. Adrean, MD, FAAO
November 14th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.